9358 Investors following GlaxoSmithKline. Share this News with them.
0
Like this story, share it with millions of investors on M3
GSK Pharma Q2 PAT seen up at Rs 128.8 cr: Motilal Oswal
Motilal Oswal has come out with its earning estimates on Pharmaceuticals Sector for the quarter ended June 2009. According to the research firm, GlaxoSmithKline Pharmaceuticals' June quarter sales are expected to go up by 13.9% to Rs 474.2 crore on YoY basis.
Motilal Oswal has come out with its earning estimates on Pharmaceuticals Sector for the quarter ended June 2009. According to the research firm, GlaxoSmithKline Pharmaceuticals ' June quarter sales are expected to go up by 13.9% to Rs 474.2 crore on YoY basis.
The company's adjusted PAT (profit after tax) is expected to go up by 12.3% to Rs 128.8 crore on YoY basis.